BCDA vs MKTX · $14.4M cap vs P/E 13, rev $817.1M
Biocardia Inc (BCDA) versus MarketAxess Holdings Inc (MKTX) — a side-by-side from cached financials, not a winner call.
Biocardia Inc (BCDA) is a biotechnology company listed on NASDAQ.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
BCDA does not have a complete income-statement cache yet.
Latest reported MKTX revenue for 2024-12-31 was $817.1M. Net income was $274.2M. Revenue was up 8.6% from 2023-12-31 to 2024-12-31. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
BCDA currently screens at market cap $14.4M. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Not investment advice. Open the BCDA and MKTX stock pages for the full models.
Not investment advice.